Glucocorticoids in central nervous system bacterial infection

Area of Science:

• Infectious Diseases
• Neurology
• Pharmacology

Background:

• Bacterial meningitis poses significant risks of mortality and long-term neurological deficits.
• Glucocorticoids, such as dexamethasone, are explored as adjunctive therapies to mitigate these outcomes.
• Evidence for their efficacy in various forms of meningitis remains under investigation.

Purpose of the Study:

• To systematically review evidence on adjunctive glucocorticoid therapy in central nervous system bacterial infections.
• To evaluate the impact of dexamethasone on outcomes in acute bacterial meningitis and tuberculous meningitis.

Main Methods:

• Literature review focusing on controlled trials of dexamethasone for acute bacterial meningitis.
• Review of studies on glucocorticoid therapy for tuberculous meningitis.
• Assessment of clinical outcomes including mortality and neurological morbidity.

Main Results:

• Conclusive evidence supports adjunctive dexamethasone for children with Haemophilus influenzae meningitis.
• Data suggest potential benefits for other bacterial meningitis and in adults, but are not conclusive.
• Supportive, but not conclusive, evidence exists for glucocorticoid use in tuberculous meningitis, especially severe cases.

Conclusions:

• Adjunctive glucocorticoid therapy is conclusively beneficial for pediatric Haemophilus influenzae meningitis.
• Further studies are required to determine optimal dexamethasone duration, its use in adult meningitis, and efficacy against other pathogens.
• Conclusive evidence is needed for the benefit of glucocorticoids in tuberculous meningitis.